JESSICA BENNETT: Open Payments
NPI 1710239215 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 89 payments from 18 companies in 2025. Trend: 2023 $2,109 · 2024 $1,293 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $304 |
| Novo Nordisk Inc | 16 | $217 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| PFIZER INC. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Exact Sciences Corporation | 4 | $63 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Corcept Therapeutics | 2 | $36 |
| Lundbeck LLC | 2 | $36 |
Products named: REXULTI, VRAYLAR, QULIPTA, Ozempic, TRELEGY ELLIPTA, UBRELVY, CAPLYTA, The Cologuard Plus Collection Kit.
Industry payments across TN — which companies pay providers there.
